Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Bracci

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
American Journal of Cancer Research|March 9, 2022
Immunomodulatory properties of CNF1 toxin from <i>E. coli</i>: implications for colorectal carcinogenesisAlessia Fabbri, Laura Bracci
Annals of the New York Academy of Sciences|June 15, 2007
IFN-alpha and novel strategies of combination therapy for cancerLaura Bracci, Enrico Proietti, Filippo Belardelli
Cytokine & Growth Factor Reviews|January 21, 2020
The role of exosomes in colorectal cancer disease progression and response to therapyLaura Bracci, Francesco Lozupone, Isabella Parolini
Frontiers in Immunology|November 16, 2020
Towards a Systems Immunology Approach to Unravel Responses to Cancer ImmunotherapyLaura Bracci, Alessandra Fragale, Lucia Gabriele, et al.
Cytokine & Growth Factor Reviews|July 12, 2017
The added value of type I interferons to cytotoxic treatments of cancerLaura Bracci, Antonella Sistigu, Enrico Proietti, et al.
Expert Review of Vaccines|April 9, 2008
Type I interferons as vaccine adjuvants against infectious diseases and cancerLaura Bracci, Valentina La Sorsa, Filippo Belardelli, et al.
Cancers|September 28, 2021
Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer TherapiesLaura Bracci, Alessia Fabbri, Manuela Del Cornò, et al.
Methods in Enzymology|February 1, 2020
Enzyme-linked immunospot assay to monitor antigen-specific cellular immune responses in mouse tumor modelsDonatella Negri, Paola Sestili, Martina Borghi, et al.
Cytokine & Growth Factor Reviews|July 16, 2020
Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?Eleonora Aricò, Laura Bracci, Luciano Castiello, et al.
Expert Review of Vaccines|October 5, 2013
Exploiting dendritic cells in the development of cancer vaccinesLaura Bracci, Imerio Capone, Federica Moschella, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
American Journal of Cancer Research|March 9, 2022
Immunomodulatory properties of CNF1 toxin from <i>E. coli</i>: implications for colorectal carcinogenesisAlessia Fabbri, Laura Bracci
Annals of the New York Academy of Sciences|June 15, 2007
IFN-alpha and novel strategies of combination therapy for cancerLaura Bracci, Enrico Proietti, Filippo Belardelli
Cytokine & Growth Factor Reviews|January 21, 2020
The role of exosomes in colorectal cancer disease progression and response to therapyLaura Bracci, Francesco Lozupone, Isabella Parolini
Frontiers in Immunology|November 16, 2020
Towards a Systems Immunology Approach to Unravel Responses to Cancer ImmunotherapyLaura Bracci, Alessandra Fragale, Lucia Gabriele, et al.
Cytokine & Growth Factor Reviews|July 12, 2017
The added value of type I interferons to cytotoxic treatments of cancerLaura Bracci, Antonella Sistigu, Enrico Proietti, et al.
Expert Review of Vaccines|April 9, 2008
Type I interferons as vaccine adjuvants against infectious diseases and cancerLaura Bracci, Valentina La Sorsa, Filippo Belardelli, et al.
Cancers|September 28, 2021
Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer TherapiesLaura Bracci, Alessia Fabbri, Manuela Del Cornò, et al.
Methods in Enzymology|February 1, 2020
Enzyme-linked immunospot assay to monitor antigen-specific cellular immune responses in mouse tumor modelsDonatella Negri, Paola Sestili, Martina Borghi, et al.
Cytokine & Growth Factor Reviews|July 16, 2020
Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?Eleonora Aricò, Laura Bracci, Luciano Castiello, et al.
Expert Review of Vaccines|October 5, 2013
Exploiting dendritic cells in the development of cancer vaccinesLaura Bracci, Imerio Capone, Federica Moschella, et al.
Pageof 4